70%+  investments in digital tools by pharma companies are unutilised.

Whitepaper by Vector Consulting Group highlights how a large part of investments in digital tools by pharma industry are unutilised

70%+ investments in digital tools by pharma companies are unutilised.

India’s EV battery market faces overcapacity. Ravindra Patki highlights limited EV demand, urging diversification across sectors and chemistries to sustain margins and meet broader energy needs beyond two- and three-wheelers.

Overcapacity alert: Battery makers’ path to profit lies beyond electric vehicles

Chandrachur Datta warns that 100% US tariffs on pharma could make oral solids unviable, causing drug shortages, price hikes, and forcing firms to reconsider market priorities.

Vector Consulting Group sees US 100% tariffs to dent oral solids and become commercially unviable

Kiran Kothekar says homegrown firms are disrupting India’s $10B advisory market — embedding in operations, co‑creating solutions, sharing risks and ensuring outcomes through hands‑on execution and AI‑driven insights.

Homegrown consulting firms seen disrupting India’s $10 billion advisory market

Indian auto industry confronts Chinese EV dominance amid shrinking product cycles, tariff disruptions, and delayed launches — experts urge urgent innovation and execution overhaul to stay globally competitive.

Indian auto industry faces innovation test amid Chinese EV dominance

Digital tools alone don’t drive results. Vector Consulting’s latest research shows pharma companies must rethink execution, adoption, and problem definition to turn tech investments into meaningful operational gains.

Study says seven of ten pharma digital projects fail to deliver despite heavy spending

Vector Consulting’s study reveals 70% of Indian pharma digital projects fail, as 89% still rely on spreadsheets—spotlighting poor scoping, adoption gaps, and the need to close the “G.A.P.” for real impact.

Seven in ten pharma digital projects fail to deliver despite heavy investments: Vector study

Vector Consulting’s study reveals 70% of pharma digital projects fail due to poor scoping, adoption issues, and resistance—highlighting the need to bridge the “G.A.P.” for real transformation.

7 out of 10 digital projects in India's pharma sector fail: Vector study

Despite rising digital investments, most pharma firms see limited impact. Vector’s new study uncovers why poor project framing, weak adoption, and misaligned execution are derailing digital transformation efforts.

Seven of ten pharma digital projects fail to deliver despite heavy spending: Vector study

Explore this section for latest updates, stories, and media coverage about our organisation from across various platforms, keeping you informed and inspired by the work we do.

Media

Welcome to Vector's media centre. Explore our latest news coverage and press releases.

Media

Let's Empower Growth